6R-BH4

DRUG3 trials

Sponsors

University of Oxford, Johns Hopkins University, Emory University

Conditions

Coronary Artery DiseaseEndothelial DysfunctionIsolated Systolic HypertensionRenal Insufficiency, Chronic

Phase 2

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

University of OxfordCoronary Artery Disease

Start: 2006-11-30End: 2009-02-28Target: 66Updated: 2008-08-07

Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction

TerminatedNCT00802893

Johns Hopkins UniversityEndothelial Dysfunction, Isolated Systolic Hypertension

Start: 2008-12-31End: 2009-05-31Updated: 2017-08-21

Neurovascular Transduction During Exercise in Chronic Kidney Disease

RecruitingNCT02947750

Emory UniversityRenal Insufficiency, Chronic

Start: 2016-10-01End: 2027-04-30Target: 150Updated: 2026-05-18

Related Papers

Exercise modulates sympathetic and vascular function in chronic kidney disease

JCI Insight2023-02-2119 citations